Table S1. Patient characteristics at AML diagnosis. Characteristics All (n = 187) CLARA arm (n = 92) HDAC arm (n = 95) p-Value Median age, years 48 50 45 0.07 Sex (male/female), n 101/86 48/44 53/42 0.66 ELN risk classification 0.41 Favorable, n (%) 1 (1) 0 1 (1) Intermediate, n (%) 137 (73) 69 (75) 68 (72) Unfavorable, n (%) 40 (21) 17 (18) 23 (24) Unknown, n (%) 9 (5) 6 (7) 3 (3) ALFA risk classification 0.66 Intermediate, n (%) 112 (60) 57 (62) 55 (58) Unfavorable, n (%) 75 (40) 35 (38) 40 (42) Remission status 0.59 CR/CRp in 1 course, n (%) 172 (92) 86 (93) 86 (91) Late CR/CRp, n (%) 15 (8) 6 (7) 9 (10) ASCT in 1 st CR, n (%) 94 (50) 48 (52) 46 (48) 0.66 Mutational status NPM1, % 26 29 23 0.39 CEBPA, % 2 2 2 1.00 FLT3-ITD, % 29 30 28 0.74 TP53, % 9 6 11 0.28 SNP alterations, median (range) 2 (0-46) 1 (0-46) 2 (0-41) 0.41 ELN, European LeukemiaNet classification according to Döhner et al. (8); ALFA, Acute Leukemia French Association; CR, complete remission; ASCT, allogeneic stem cell transplantation.

